258 related articles for article (PubMed ID: 29274021)
1. Clinical characteristics and ophthalmologic findings of pituitary adenoma in Korean patients.
Kim TG; Jin KH; Kang J
Int Ophthalmol; 2019 Jan; 39(1):21-31. PubMed ID: 29274021
[TBL] [Abstract][Full Text] [Related]
2. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma.
Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV
J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.
Cennamo G; Auriemma RS; Cardone D; Grasso LF; Velotti N; Simeoli C; Di Somma C; Pivonello R; Colao A; de Crecchio G
Eye (Lond); 2015 Jun; 29(6):797-802. PubMed ID: 25853400
[TBL] [Abstract][Full Text] [Related]
4. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression.
Gan L; Ma J; Feng F; Wang Y; Cui J; Guo X; Zhang X; You H; Wang Z; Yin Z; Zhong Y; Xing B
World Neurosurg; 2018 Aug; 116():e960-e967. PubMed ID: 29857216
[TBL] [Abstract][Full Text] [Related]
5. The Chiasmal Compression Index: An Integrative Assessment Tool for Visual Disturbances in Patients with Pituitary Macroadenomas.
Avraham E; Azriel A; Melamed I; Alguayn F; Al Gawad Siag A; Aloni E; Sufaro Y
World Neurosurg; 2020 Nov; 143():e44-e50. PubMed ID: 32562903
[TBL] [Abstract][Full Text] [Related]
6. Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma.
Gedik S; Gur S; Atalay B; Colak M; Altinors N; Akova YA
Saudi Med J; 2007 Sep; 28(9):1380-4. PubMed ID: 17768464
[TBL] [Abstract][Full Text] [Related]
7. Clinical features associated with lesions other than pituitary adenoma in patients with an optic chiasmal syndrome.
Mejico LJ; Miller NR; Dong LM
Am J Ophthalmol; 2004 May; 137(5):908-13. PubMed ID: 15126157
[TBL] [Abstract][Full Text] [Related]
8. Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.
Lee IH; Miller NR; Zan E; Tavares F; Blitz AM; Sung H; Yousem DM; Boland MV
AJR Am J Roentgenol; 2015 Nov; 205(5):W512-8. PubMed ID: 26496573
[TBL] [Abstract][Full Text] [Related]
9. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
[TBL] [Abstract][Full Text] [Related]
10. Association of retinal nerve fibre layer thickness with quantitative magnetic resonance imaging data of the optic chiasm in pituitary adenoma patients.
Glebauskiene B; Liutkeviciene R; Zlatkute E; Kriauciuniene L; Zaliuniene D
J Clin Neurosci; 2018 Apr; 50():1-6. PubMed ID: 29398198
[TBL] [Abstract][Full Text] [Related]
11. Visual field defects in patients with pituitary adenomas.
Huang WC; Lee LS
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):245-51. PubMed ID: 9509679
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of secondary white matter injury in the visual pathway by pituitary adenomas: a multimodal study at 7-Tesla MRI.
Rutland JW; Padormo F; Yim CK; Yao A; Arrighi-Allisan A; Huang KH; Lin HM; Chelnis J; Delman BN; Shrivastava RK; Balchandani P
J Neurosurg; 2019 Jan; 132(2):333-342. PubMed ID: 30660127
[TBL] [Abstract][Full Text] [Related]
13. The role of optical coherence tomography in the detection of pituitary adenoma.
Johansson C; Lindblom B
Acta Ophthalmol; 2009 Nov; 87(7):776-9. PubMed ID: 18771481
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of Tumor-Related Edema of Optic Tract Affecting Visual Function in Patients with Sellar and Suprasellar Tumors.
Ju DG; Jeon C; Kim KH; Park KA; Hong SD; Seoul HJ; Shin HJ; Nam DH; Lee JI; Kong DS
World Neurosurg; 2019 Dec; 132():e862-e868. PubMed ID: 31394363
[TBL] [Abstract][Full Text] [Related]
15. Visual field defects in 23 acromegalic patients.
Kan E; Kan EK; Atmaca A; Atmaca H; Colak R
Int Ophthalmol; 2013 Oct; 33(5):521-5. PubMed ID: 23397103
[TBL] [Abstract][Full Text] [Related]
16. Pituitary Macroadenoma Presenting With Monocular Temporal Hemianopia.
Gupta A; Deshmukh M; Palexas G
J Neuroophthalmol; 2021 Jun; 41(2):e267-e268. PubMed ID: 33136669
[TBL] [Abstract][Full Text] [Related]
17. Factors Influencing Visual Field Recovery after Transsphenoidal Resection of a Pituitary Adenoma.
Lee DK; Sung MS; Park SW
Korean J Ophthalmol; 2018 Dec; 32(6):488-496. PubMed ID: 30549473
[TBL] [Abstract][Full Text] [Related]
18. The volume of tumor mass and visual field defect in patients with pituitary macroadenoma.
Lee JP; Park IW; Chung YS
Korean J Ophthalmol; 2011 Feb; 25(1):37-41. PubMed ID: 21350693
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.
Monteiro ML; Zambon BK; Cunha LP
Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089
[TBL] [Abstract][Full Text] [Related]
20. Multifocal visual evoked potential recordings in compressive optic neuropathy secondary to pituitary adenoma.
Jayaraman M; Ambika S; Gandhi RA; Bassi SR; Ravi P; Sen P
Doc Ophthalmol; 2010 Dec; 121(3):197-204. PubMed ID: 20821036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
